Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MEGHANA TRIVEDI and BIN GUO.
MEGHANA TRIVEDI
Connection Strength
0.242
BIN GUO
  1. Targeting the IRE1a-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcoma. Commun Biol. 2026 May 06; 9(1).
    View in: PubMed
    Score: 0.061
  2. Targeting the IRE1a-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcoma. bioRxiv. 2026 Apr 20.
    View in: PubMed
    Score: 0.061
  3. TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma. Oncogene. 2026 May; 45(18):1714-1728.
    View in: PubMed
    Score: 0.061
  4. TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma. bioRxiv. 2025 Nov 05.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.